
[Federal Register: September 1, 2010 (Volume 75, Number 169)]
[Notices]               
[Page 53701]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01se10-67]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0394]

 
Clinical Studies of Safety and Effectiveness of Orphan Products 
Research Project Grant (R01); Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of August 6, 2010 (75 FR 47602). 
The document announced the availability of grant funds for the support 
of FDA's Office of Orphan Products Development (OPD) grant program. The 
document was published with an error. This document corrects that 
error.

FOR FURTHER INFORMATION CONTACT: Vieda Hubbard, Acquisition Support and 
Grants, Food and Drug Administration, 5630 Fishers Lane, Rockville, MD 
20857, 301-827-7177, email: vieda.hubbard@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In FR Doc. 2010-19354, appearing on page 
47602 in the Federal Register of Friday, August 6, 2010, the following 
correction is made:
    1. On page 47602, in the second column, in the ``DATES'' section, 
beginning in the sixth line, the sentence ``2. The anticipated start 
dates are November 2010; November 2012.'' is corrected to read ``2. The 
anticipated start dates are November 2011 and November 2012.''

    Dated: August 26, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-21795 Filed 8-31-10; 8:45 am]
BILLING CODE 4160-01-S

